Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7851489 Pyridinone compounds

Patent 7851489 was granted and assigned to Bristol-Myers Squibb on December, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
Date Filed
November 8, 2007
Date of Patent
December 14, 2010
Patent Application Number
11936984
Patent Citations Received
‌
US Patent 12084443 Process of preparing a PD-1/PD-L1 inhibitor
0
‌
US Patent 11866434 Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
0
‌
US Patent 11866451 Salts and crystalline forms of a PD-1/PD-L1 inhibitor
0
‌
US Patent 11873309 Heterocyclic compounds as immunomodulators
0
‌
US Patent 11673883 Heterocyclic compounds as immunomodulators
0
‌
US Patent 11753406 Salts of a PD-1/PD-L1 inhibitor
‌
US Patent 11760756 Crystalline form of a PD-1/PD-L1 inhibitor
‌
US Patent 11780836 Process of preparing a PD-1/PD-L1 inhibitor
‌
US Patent 11787793 Heterocyclic compounds as immunomodulators
‌
US Patent 11866435 Heterocyclic compounds as immunomodulators
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7851489
Patent Primary Examiner
‌
Zinna N. Davis

Find more entities like US Patent 7851489 Pyridinone compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo